MHY-1685

CAS No. 27406-31-1

MHY-1685( 5-(4-hydroxyphenyl)methylenehexahydropyrimidine-2,4,6-trione )

Catalog No. M28290 CAS No. 27406-31-1

MHY-1685 is a mammalian target of rapamycin (mTOR) inhibitor and a senescence inhibitor that can rejuvenate senile hCSCs by modulating autophagy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 26 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MHY-1685
  • Note
    Research use only, not for human use.
  • Brief Description
    MHY-1685 is a mammalian target of rapamycin (mTOR) inhibitor and a senescence inhibitor that can rejuvenate senile hCSCs by modulating autophagy.
  • Description
    MHY-1685 is a mammalian target of rapamycin (mTOR) inhibitor and a senescence inhibitor that can rejuvenate senile hCSCs by modulating autophagy.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    5-(4-hydroxyphenyl)methylenehexahydropyrimidine-2,4,6-trione
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    mTOR
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    27406-31-1
  • Formula Weight
    232.195
  • Molecular Formula
    C11H8N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 62.5 mg/mL (269.18 mM)
  • SMILES
    Oc1ccc(C=C2C(=O)NC(=O)NC2=O)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sánchez-Hernández E, et al. Physicochemical Characterization and Antimicrobial Activity against Erwinia amylovora, Erwinia vitivora, and Diplodia seriata of a Light Purple Hibiscus syriacus L. Cultivar. Plants (Basel). 2021 Sep 10;10(9):1876.
molnova catalog
related products
  • MTI-31

    MTI-31 (LXI-15029, mTOR inhibitor-31) is a novel potent, selective mTORC1/mTORC2 inhibitor with Kd of 0.2 nM (mTOR).

  • WYE-354

    WYE-354 is a potent, selective and ATP-competitive inhibitor of mTOR with IC50 of 5 nM (recombinant mTOR ).

  • CC-115

    A novel dual inhibitor of mTOR and DNA-PK with IC50 of 21 nM and 13 nM, respectively.